Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
25.70
+0.40 (1.58%)
Nov 17, 2025, 1:13 PM CET
1.58%
Market Cap117.99M
Revenue (ttm)250.00K
Net Income (ttm)-24.38M
Shares Out4.66M
EPS (ttm)-5.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume210
Average Volume1,874
Open25.20
Previous Close25.30
Day's Range25.20 - 25.90
52-Week Range22.70 - 49.30
Beta0.78
RSI43.99
Earnings DateNov 19, 2025

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 33
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.